stella
beta
EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma — Stella
Recruiting
Back to Nasopharyngeal Cancinoma (NPC) trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong
View full record on ClinicalTrials.gov